Your browser doesn't support javascript.
loading
Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter, Andreas; Cheng, Liqin; Hu, Yue O O; Svensson, Mikaela; Pennhag, Alexandra A L; Ursu, Ramona G; Haeggblom, Linnea; Grün, Nathalie; Ramqvist, Torbjörn; Engstrand, Lars; Dalianis, Tina; Du, Juan.
Afiliação
  • Ährlund-Richter A; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Cheng L; Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research, Karolinska Institutet, Stockholm, Sweden.
  • Hu YOO; Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research, Karolinska Institutet, Stockholm, Sweden.
  • Svensson M; Science for Life Laboratory, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden.
  • Pennhag AAL; Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research, Karolinska Institutet, Stockholm, Sweden.
  • Ursu RG; Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research, Karolinska Institutet, Stockholm, Sweden.
  • Haeggblom L; Science for Life Laboratory, Department of Microbiology, Tumor and Cell Biology, Stockholm, Sweden.
  • Grün N; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Ramqvist T; Department of Microbiology (Bacteriology, Virology) and Parasitology, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
  • Engstrand L; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Dalianis T; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Du J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Article em En | MEDLINE | ID: mdl-30949454

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Colo do Útero / Infecções por Papillomavirus / Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18 Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans País/Região como assunto: Europa Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Colo do Útero / Infecções por Papillomavirus / Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18 Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans País/Região como assunto: Europa Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2019 Tipo de documento: Article